Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-211-8 | CAS number: 7447-40-7
Carcinogenicity
Administrative data
Description of key information
Overall, there is no evidence of treatment-related carcinogenicity in rats administered potassiumchlorider up to 1820 mg/kg bw/day via food over a period of 2 years.
Key value for chemical safety assessment
Justification for classification or non-classification
Based on the availble data no classification/labelling is proposed.
Additional information
oral application
In a long term study performed with KCl, no carcinogenic effects were observed in male rats, Groups of 50 male F344/Slc rats were fed KCl in the diet at levels of 110, 450, 1820 mg/kg bw/day for 2 years. A comprehensive examination of the tissue revealed no evidence of treatment related carcinogenicity. Among non-tumerous lesions nephrotic lesion was predominant in all treatment groups as well as in the control group. In tumerous lesions testicular tumour (interstititial cell tumour) developed with a high incidence in all groups including controls. However, the incidence and type of tumour in experimental and control groups were comparable to those of sponateous tumours in the test organism (Imai 1961, UNEP 2003)
In an other study male and female Wistar rats were fed diets containing 0 or 3 % KCL over a total period of 30 months: Examination after 13 weeks (10 rats/sex/group), after 18 months (15 rats/sex/group) and after 30 months (50 rats/sex /group). Due to the reduction of feed intake the mean test substance intake and mean body weight decreased in time. After 30 months treatment, histopathologically in the adrenals, zona glomerulosa: hypertrophy in 24/50 treated rats versus 4/50 in controls, and in the urinary bladder: cystitis (males: 3/59; females 3/50) and single epithelial hyperplasia (males 3/50; females 2/50)were the only observed changes (Lina 1994, 2004)
Overall, there is no evidence of treatment-related carcinogenicity in rats administered potassiumchlorider up to 1820 mg/kg bw/day via food over a period of 2 years
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
